Brokerages Set Clarivate PLC (NYSE:CLVT) Target Price at $3.22

Shares of Clarivate PLC (NYSE:CLVT) have received a consensus recommendation of “Reduce” from the eight ratings firms that are covering the firm, MarketBeat Ratings reports. Three research analysts have rated the stock with a sell recommendation and five have given a hold recommendation to the company. The average twelve-month target price among brokers that have issued a report on the stock in the last year is $3.2333.

A number of research firms have recently commented on CLVT. Wall Street Zen raised Clarivate from a “hold” rating to a “buy” rating in a research report on Saturday, May 2nd. Weiss Ratings reiterated a “sell (e+)” rating on shares of Clarivate in a research report on Wednesday, June 24th. Finally, Barclays increased their target price on Clarivate from $2.40 to $2.50 and gave the stock an “underweight” rating in a research note on Tuesday, July 7th.

Clarivate Trading Up 1.6%

Shares of CLVT stock traded up $0.04 on Friday, hitting $2.23. The stock had a trading volume of 8,018,433 shares, compared to its average volume of 9,558,693. The company has a current ratio of 0.84, a quick ratio of 0.84 and a debt-to-equity ratio of 0.89. Clarivate has a twelve month low of $1.66 and a twelve month high of $4.77. The company has a fifty day moving average price of $2.39 and a two-hundred day moving average price of $2.54. The firm has a market cap of $1.43 billion, a P/E ratio of -10.64 and a beta of 1.38.

Clarivate (NYSE:CLVT) last issued its quarterly earnings data on Wednesday, April 29th. The company reported $0.18 EPS for the quarter, topping the consensus estimate of $0.14 by $0.04. The business had revenue of $585.50 million for the quarter, compared to the consensus estimate of $569.50 million. Clarivate had a positive return on equity of 8.82% and a negative net margin of 5.61%.The firm’s revenue was down 1.4% compared to the same quarter last year. During the same quarter last year, the business posted $0.14 EPS. Clarivate has set its FY 2026 guidance at 0.700-0.800 EPS. As a group, analysts forecast that Clarivate will post 0.65 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Clarivate

Several large investors have recently made changes to their positions in the stock. Personal CFO Solutions LLC acquired a new stake in shares of Clarivate during the first quarter worth $30,000. FreeGulliver LLC bought a new position in Clarivate during the 1st quarter worth about $30,000. Principal Financial Group Inc. bought a new position in Clarivate during the 1st quarter worth about $32,000. M&T Bank Corp acquired a new stake in shares of Clarivate in the 4th quarter valued at about $34,000. Finally, Parallel Advisors LLC raised its stake in shares of Clarivate by 94.2% in the 1st quarter. Parallel Advisors LLC now owns 13,786 shares of the company’s stock valued at $35,000 after purchasing an additional 6,687 shares during the period. Institutional investors own 85.72% of the company’s stock.

About Clarivate

Clarivate plc is a global information and analytics company that provides insights and workflow solutions to accelerate the pace of innovation. The company delivers proprietary data, analytics, and expertise to support research and development in the life sciences, intellectual property management, academic institutions, government agencies, and corporations. Its core offerings include citation and patent databases, drug pipeline analytics, trademark research tools, regulatory compliance solutions, and market intelligence platforms.

Originally part of Thomson Reuters’ Intellectual Property & Science division, Clarivate was established as an independent entity in 2016 following a spin-off transaction.